Weill Cornell Medical Center — New York, New York

Public research footprint of Weill Cornell Medical Center, compiled from the ClinicalTrials.gov public registry.

517

Registered studies

212

Active

Recruiting now

221

Completed

Stopped or withdrawn

Most-studied conditions

EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT06876714 — ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+… (Recruiting)
NCT03866382 — Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Weill Cornell Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.